Evidence map›Paper›PMID 30920516›Full record

ArticleGels (Basel, Switzerland)2017

A Controlled Antibiotic Release System for the Development of Single-Application Otitis Externa Therapeutics.

Bogdan A Serban, Kristian T Stipe, Jeremy B Alverson, Erik R Johnston, Nigel D Priestley, Monica A Serban

Open access · goldAbstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bogdan A SerbanMaterials Science Program, University of Montana, Missoula, MT 59812, USA. bogdan.serban@mso.umt.edu.
Kristian T StipeInterdisciplinary Studies Program, University of Montana, Missoula, MT 59812, USA. kristian.stipe@umontana.edu.
Jeremy B AlversonDepartment of Chemistry and Biochemistry, University of Montana, Missoula, MT 59812, USA. jeremy.alverson@umconnect.umt.edu.
Erik R JohnstonMaterials Science Program, University of Montana, Missoula, MT 59812, USA. erik.johnston@umconnect.umt.edu.
Nigel D PriestleyDepartment of Chemistry and Biochemistry, University of Montana, Missoula, MT 59812, USA. nigel.priestley@mso.umt.edu.
Monica A SerbanMaterials Science Program, University of Montana, Missoula, MT 59812, USA. monica.serban@umontana.edu.
University of Montana · US

Funding

Surveillance genome sequencing to detect SARS-CoV-2 virus variants in MontanaP20GM103546 · NIGMS · UNIVERSITY OF MONTANA · PI BOWLER, BRUCE E · 2012 to 2021
$19.2M
NIGMS NIH HHS P20 GM103546
6 · The paper itself

Abstract

Ear infections are a commonly-occurring problem that can affect people of all ages. Treatment of these pathologies usually includes the administration of topical or systemic antibiotics, depending on the location of the infection. In this context, we sought to address the feasibility of a single-application slow-releasing therapeutic formulation of an antibiotic for the treatment of otitis externa. Thixotropic hydrogels, which are gels under static conditions but liquefy when shaken, were tested for their ability to act as drug controlled release systems and inhibit

Indexed as

antibacterialdrug releasehydrogeloticthixotropic

Identifiers

PMID30920516
PMCPMC6318594
OpenAlexW2616147902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.